NantOmics, LLC
62Patents
62Active
62Granted
56Portfolio score
Filing activity: Oct 24, 2013 → Mar 25, 2024
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10050959B2 | Synthetic genomic variant-based secure transaction devices, systems and methods | Emerging Cross-Sectional Technologies | 48 | Active |
| US11461690B2 | Distributed machine learning systems, apparatus, and methods | Physics | 13 | Active |
| US11785004B2 | Synthetic genomic variant-based secure transaction devices, systems and methods | Emerging Cross-Sectional Technologies | 8 | Active |
| US10607343B2 | Digital histopathology and microdissection | Physics | 7 | Active |
| US10769788B2 | Few-shot learning based image recognition of whole slide image at tissue level | Physics | 5 | Active |
| US11421016B2 | Cancer neoepitopes | Chemistry; Metallurgy | 4 | Active |
| US11954596B2 | Weakly supervised learning with whole slide images | Physics | 3 | Active |
| US11694122B2 | Distributed machine learning systems, apparatus, and methods | Physics | 3 | Active |
| US11948687B2 | Deep learning models for region-of-interest determination | Physics | 2 | Active |
| US10347361B2 | Genome explorer system to process and present nucleotide variations in genome sequence data | Physics | 2 | Active |
| US10532089B2 | Iterative discovery of neoepitopes and adaptive immunotherapy and methods therefor | Physics | 2 | Active |
| US11443426B2 | Real-time whole slide pathology image cell counting | Physics | 2 | Active |
| US12052240B2 | Synthetic genomic variant-based secure transaction devices, systems and methods | Emerging Cross-Sectional Technologies | 1 | Active |
| US11195062B2 | Classification based on characterization analysis methods and systems | Physics | 1 | Active |
| US10339274B2 | Viral neoepitopes and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US11504420B2 | AGGF1 immunogenic compositions | Chemistry; Metallurgy | 1 | Active |
| US11954856B2 | Real-time whole slide pathology image cell counting | Physics | 1 | Active |
| US11785002B2 | Synthetic genomic variant-based secure transaction devices, systems and methods | Emerging Cross-Sectional Technologies | 1 | Active |
| US11682195B2 | Digital histopathology and microdissection | Physics | 1 | Active |
| US10467523B2 | Methods and systems for predicting DNA accessibility in the pan-cancer genome | Physics | 1 | Active |
| US12094574B2 | Difference-based genomic identity scores | Physics | 0 | Active |
| US11393557B2 | Systems and methods for high-accuracy variant calling | Physics | 0 | Active |
| US10525040B2 | Compositions and methods of Rit1 inhibition | Human Necessities | 0 | Active |
| US10722531B2 | OPRT expression and cancer treatment outcome | Physics | 0 | Active |
| US12205033B2 | Weakly supervised learning with whole slide images | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.